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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) characteristi-
cally manifests as chronic airflow obstruction due to terminal bron-
chiolar and alveolar destruction. In 2007, the World Health Organi-
zation estimated that 64 million people have COPD, and that 3
million people died off the disease. Its incidence is currently in-
creasing, and it is estimated to become the third leading cause of
death in 2020 (1, 2). Destruction of pulmonary alveoli is considered
irreversible, and no curative therapy has been developed to repair
the apoptotic lesion. In 1990s, interest grew in the proposal to
perform lung volume reductions surgery for COPD. However, the
National Emphysema Treatment Trial, which was a large-scale
clinical trial conducted in the USA in 2003, found limitations in
the appropriateness of this treatment (3). In 1997, Massaro et al.
reported that administration of all - trans retinoic acid caused a
reduction of emphysematous lesions in rat lung (4). While their
research reached the stage of clinical trials, unfortunately it did
not yield the expected therapeutic results (5). Currently, the only
effective radical treatment for COPD is lung transplantation from
a live donor or brain-dead healthy body. However, the serious
shortage of donors limits the practicality of whole- lung transplan-
tation and highlights the urgent need to develop new treatment
methods.
Advances in regenerative sciences in recent years have been re-
markable. In addition to the bone marrow stem cells and progenitor
cells that were originally recognized in the field, tissue stem cells
have been subsequently found to exist in many organs. Stem cells
and potential applications have also been discovered in the field
of pulmonology (6, 7). However, in comparison to solid organs
such as liver or heart, regeneration of the lung with stem cells is
considered difficult. A single type of lung cell is insufficient to re-
store the complicated structure of the lung. A cell source with the
highest potential and a scaffold suitable for lung development are
also necessary. To attempt to solve this problem, we focused on
fetal lung, which has excellent potential for further growth, differ-
entiation, and proliferation, and mesenchymal tissue as a suitable
scaffold. We have previously shown that fetal rat lung tissues were
able to survive, grow, and differentiate inside adult rat lung (8).
In this study, we investigated whether fetal lung tissue was also
able to grow and differentiate in the adult lung of a mouse strain
used as a disease model of pulmonary emphysema. While many
pulmonary emphysema models exist (4, 9 -11), we chose the pallid
mice as recipients. In a previous study, we examined the exercise
function of pallid mice and reported that they show decreased ex-
ercise capacity and diminished respiratory function antecedent
to histological changes (12). If pulmonary regeneration can be
achieved in pallid mice, it may lead to further functional investi-
gation of lung regeneration with fetal tissue.
MATERIALS AND METHODS
Animals
Pallid mice (C57 pa+/pa+), which were used as recipient mice,
were purchased from Jackson Laboratory (Bar Harbor, ME, USA)
via Charles River Japan (Kanagawa, Japan). Green fluorescent pro-
tein (GFP)-C57BL/6 mice were used as donors and provided by
the Research Institute for Microbial Diseases, Osaka University,
Japan (13). These mice were bred in a pathogen-free environment
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with a 12 h light-dark cycle, and provided free access to water and
food. All animal care and experiments were carried out in accor-
dance with the institutional and national guidelines (Japanese
Ministry of Education, Culture, Sports, Science and Technology)
and were approved by the Animal Care Committee of the Univer-
sity of Tokushima.
Measurement of mean linear intercept to evaluate pulmonary em-
physema
Two groups of 6 naïve pallid mice were killed at 3 and 12 months
of age, respectively. The left lungs were removed and fixed with
10% phosphate-buffered formaline solution through the trachea
at a pressure of 15 cm H2O. Specimens obtained from the upper,
middle and lower fields of the left lung were cut into 4-μm-thick
sections and stained with hematoxylin and eosin.
We used the mean linear intercept (Lm) method to quantify the
alveolar space and evaluated pulmonary emphysema (14). Five
fields under a light microscope at200 magnification were ran-
domly selected from each sections (i.e. 15 fields in each left lung
sample), and Lm was calculated on the basis of the total number
of a alveolar intercepts encountered along the length of a right-
angled crosshair (500 μm). The differences among Lm values of
the upper, middle, and lower fields of the left lung were analyzed
by one-way analysis of variance (ANOVA) with Bonferroni correc-
tion. The difference between the Lm values of the left lung at 3 and
12 months of age was analyzed by Mann Whitney U test. All statis-
tical analyses were performed with SPSS version 23.0. P0.05 was
considered to indicate statistical significance.
Implantation
Pregnant GFP-C57BL/6 mice at 16 days’ gestation were eutha-
nized under ether anesthesia, and fetuses were removed. Donor
fetal lungs were dissected under a microscope and then finely cut
with scissors into small pieces in Dulbecco’s modified Eagle’s
medium containing 10% fetal bovine serum, 200 U/ml penicillin,
and 200 μl/ml streptomycin (GIbco-BRL).
Fifteen 12-month-old pallid mice were used as recipients. They
were intubated with 22-G Surflo external cylinders (Terumo, Tokyo,
Japan) under anesthesia by intraperitoneal injection of xylazine
(8 mg/kg) and ketamine hydrochloride (80 mg/kg), and then
placed in a lateral position. A small animal respirator (KN-55,
Natsume Factory, Tokyo, Japan) was used to establish ventilation
at a respiratory rate of 150 cycles/min and a tidal volume of 0.2 ml/
body. After left thoracotomy, the finely minced fetal lung pieces
were injected into the lower half of the left lung using a 25-μl
microsyringe (Hamilton, USA) with a 26-gauge needle. To prevent
pneumothorax, the pinhole of the lung at the injection site was
closed off with a silk ligature, and the peripheral lung tissue from
the ligature was resected. To control for rejection of the GFP an-
tigen, 10 mg/kg cyclosporine (CyA, Novartis) was administered
intramuscularly into the quadriceps daily from the day before
surgery until the day of sacrifice.
Histological study
The recipient mice were sacrificed at day 7, 14, and 28 after
implantation (5 animals per time point) and used for histological
examination. After cutting the left atrium, lungs were perfused with
saline through the pulmonary artery and then removed en bloc
with the heart and fixed in a fixing solution (4 : 1 ratio of 4% para-
formaldehyde to Optimal Cutting Temperature [OCT] compound)
through the trachea at a pressure of 15 cm H2O. After fixation for
5 h at 4, the implanted tissue was identified and fixed with OCT
compound at -80. Sections were prepared at 10-μm thickness
for fluorescence microscopy to evaluate green fluorescence, and
4-μm thickness for hematoxylin and eosin staining. Both non-
stained histological images and green fluorescent images were
captured using a Biozero BZ-8000 microscope (Keyence Co, Ltd,
Osaka, Japan), and light microscopic images from histologic speci-
mens with hematoxylin-eosin stain were captured using an Olympus
BX51-FL microscope (Olympus Co, Ltd, Tokyo, Japan).
RESULTS
Evaluation of emphysematous change in pallid mice using the Lm
method.
To evaluate whether our pallid mice were suitable as a pulmonary
emphysema models, we first compared the histological changes
between 3- and 12-month-old pallid mice and evaluated Lm. Com-
pared with 3-month-old pallid mice, 12-month-old pallid mice
demonstrated well -developed morphological features of pulmo-
nary emphysema (Figure 1A). The Lm of pallid mice at 12 months
of age was significantly higher than that of pallid mice at 3 months
of age (P0.01). We also observed whether any bias of Lm was
present within the upper, middle, and lower fields of the lung. Little
variation was observed in the distribution of emphysematous le-
sions within each field (Figure 1B).
Morphologic changes of GFP-fetal lung tissues in the emphy-
semic lung.
The morphology of lungs from fetal mice at day 16 and neonatal
mice at days 7 and 14 is presented to provide landmarks for lung
maturation (Figure 2A-C). Day 16 corresponds to the pseudoglan-
dular period of mouse lung development, which covers the estab-
lishment of the undifferentiated primordial system of the developing
lung and the appearance of the prospective bronchial and respira-
tory systems. Development of the bronchial and respiratory sys-
tems proceeds in the canalicular, terminal sac, and alveolar peri-
ods. The alveolar period lasts for 4 weeks after birth (15).
At 7 days after implantation, the grafted tissue still contained
some structures with pseudoglandular - like shape. However, some
air - filled structures were also observed, with thick septal walls
similar to those seen in day-7 postnatal lung. The border between
donor and host tissue were clearly existed, however, continuous
connections between them were detected. The host alveoli adja-
cent to transplanted fetal tissues were compressed (Figure 3A-C).
At 14 days after implantation, alveoli were further developed.
The alveolar wall became thinner, and the alveolar space became
larger. A relatively thick septal wall remained between alveoli com-
posed of cuboidal epithelial cells and matrix. The host alveoli ad-
jacent to transplanted fetal tissues were also compressed at this
time (Figure 3D-F).
At 28 days after implantation, the alveolar wall in the injected
tissue became thinner than that at day 14. Moreover, the alveolar
spaces were expanded, mimicked to that in a normal adult lung.
In the border zone between the implanted fetal lung tissue and the
adult lung tissue, the connection of alveolar wall between them
became smoother. The compression of host alveoli by transplanted
fetal tissues does not observed (Figure 3G-I). This sequence of
events indicated that fetal lung tissue also grows and differenti-
ates in the adult lung of a mouse genetic model of pulmonary em-
physema.
With the use of a fluorescence microscope, the border and distri-
bution of the recipient lung could be clearly distinguished by the
luminescence of grafts. The differentiated fluorescent tissue was
seen inside the implanted tissue area. However, no fluorescent tis-
sue spreading into the recipient lung was detected. The extremely
light fluorescence in the recipient lung was the autofluorescence.
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DISCUSSION
To date, several studies regarding pulmonary regeneration have
been reported, with some describing transplantation of individual
cells, such as alveolar type 2 cells (16-18). However, individual
pulmonary cells transplanted into lung are presumed insufficient
to achieve regeneration at the organ level. Concomitant regeneration
of the vascular system, scaffold, and interstitial components are
additionally required.
To surmount this difficulty, we previously used fetal rat lung
fragments for implantation (8), which contains various cells with
the potential to differentiate into pulmonary tissue. In that study,
we demonstrated that fetal rat lung tissues were capable of differen-
tiation inside host adult lungs. In the present study, we used mice
that spontaneously develop pulmonary emphysema as recipients
and showed that implanted lung tissues from fetal mice survived
and differentiated in this disease model of pulmonary emphysema.
While many pulmonary emphysema models exist (4, 9-11), those
induced by intra- tracheal administration of chemical agents show
some bias in emphysematous grade and distribution, which are in-
adequate models for tissue implantation because of the possibility
of little emphysematous grade at the site of implantation. Pallid
mice have a C57BL/6 origin, and they carry a mutation in the pallid
gene, which is located on chromosome 2. They characteristically
develop spontaneous pulmonary emphysema at 12-15 months of
age due to a deficiency in α -antitrypsin (19, 20). Kei et al.measured
Lm at 1, 12, and 24 months of age in pallid and C57BL/6 mice and
reported a significant difference at 12 months (21). Consistent with
their data, in our study, we observed significantly higher Lm at 12
months of age in pallid mice and little variation in the distribution of
Figure 1
(A) Representative hematoxylin and eosin-stained specimens of pallid mice at 3 and 12 months of age (200). 12 -month-old pallid mice demon-
strated well -developed morphological features of pulmonary emphysema.
(B) Evaluation of emphysematous change in pallid mice using the Lm method. The Lm of 12-month-old pallid mice was significantly higher than
that of 3 -month-old pallid mice (P0.01). Data are presented as meanstandard deviation in each group of 6 animals. There was little bias of Lm
within the upper, middle, and lower fields of the lung.
Figure2
Landmarks of lung maturation . The morphology of fetal mouse lung at day 16 (A) and neonatal mouse lung at days 7 (B) and 14 (C) is presented to
indicate landmarks of lung maturation. (hematoxylin and eosin staining,200)
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emphysematous lesions within each field. Therefore, we regarded
pallid mice as feasible models of pulmonary emphysema for ex-
periments with fetal lung implantation.
The development course of fetal mouse and rat lung are normally
almost identical (15, 22), however, compared with the implanted
grafts in normal rats we previously reported, which demonstrated
the beginning of alveolar expansion at 4 weeks (8, 23), grafts im-
planted in pallid mice demonstrated expanded air spaces earlier.
We postulate two possible reasons for this difference. (1) The turn-
over of alveolar wall cells is enhanced in emphysematous lungs
(24). This environment may produce some positive effect on fetal
tissue differentiation. (2) Although the fetal mouse lung tissues
were cut into small pieces under the same procedure used for the
rat models, the size of the implanted grafts in proportion to body
size was greater in the mouse than in the rat models because the
former are smaller. Therefore, the courses in mice might have
been similar to those of organ transplantation models.
In addition, in the rats, the implanted alveolar units of the fetal
lung became extremely larger than the surrounding alveolar units
in the recipients. In contrast, in the pallid mice, the implanted al-
veolar units were slightly smaller than the surrounding alveolar
units (those without emphysematous change). The reasons for this
may be that the alveoli in the pallid mice were compressed by the
surrounding emphysematous tissue, and that the mechanical stimu-
lation produced by partial lung resection was not effective in the
implanted fetal lung tissue, with the surrounding emphysematous
tissue instead showing expansion of the high compliance area.
We previously reported that the pallid mouse showed decreased
exercise capacity and diminished respiratory function from ap-
proximately 6 months of age (12). We attempted to investigate the
exercise capacity of fetal - lung- implanted pallid mice in comparison
to pallid mice that had not undergone surgery. However, due to the
invasive nature of the large thoracotomy, the exercise function of
the recipient mice decreased postoperatively. (deta not shown)
We are left with the issue of how to establish more diffuse and less
invasive transplantation methods to carry out postoperative evalu-
ations of respiratory and exercise function. Transplanting fetal lung
tissues through the airway or lung blood vessels may be a possible
solution ; however, suffocation or pulmonary embolism was un-
avoidable with massive fetal lung tissue injection. We must now
identify which cells in the fetal mouse lung play key roles for tissue
growth and aim to implant the minimum number of those cells
necessary to differentiate in recipient lung. Takebe et al. reported
organ bud formation including lung by combining tissue specific
progenitor cells, endothelial cells, and mesenchymal stem cells
(25).
The ultimate goal of tissue engineering of the lung may be to
induce differentiation of stem cells such as induced pluripotent
stem cells into various respiratory cells, reconstructing 3-dimen-
sional architectural features of alveoli with these cells and a scaf-
fold, and transplanting them into lung. A recent report described
differentiation of human pluripotent stem cells to basal, goblet,
Clara, ciliated, type I and type II alveolar epithelial cells (26), how-
ever, the issue of reconstructing complex alveolar structure still
remains unresolved. Petersen et al. reported a method of devel-
oping a scaffold from extracted rat lungs ; the cellular components
were removed with detergent solutions and remaining airway and
vasculature structures served as a scaffold. However, generating
a scaffold from the cellular level remains difficult (27). Our method,
to regenerate lung using fetal lung tissue, resolves both problems.
We believe that our success regenerating emphysematous lungs
of pallid mice using fetal lung tissue, along with further investigation
Figure3
Morphologic change of fetal lung tissue implanted in emphysematous lungs of pallid mice. Fetal lung tissues and surrounding areas were examined
at 7 (A-C), 14 (D-F), and 28 days (G-I) after implantation. Unstained specimens were observed under white light (A, D, G) and fluorescence (B, E, H)
microscopy (100). Green fluorescence clearly demonstrates the border zones and smooth connection between the donor and recipient tissue.
Hematoxylin and eosin-stained specimens (C, F, I) are shown at 200magnification. Arrows indicate the border zone between injected and native
tissue. Air space expansion and morphologic changes of the donor tissue were observed over time. Each photo is representative of 5 animals that
were treated as described in the Materials and Methods.
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of respiratory and exercise function in this model, will lead to fur-
ther research and advances in the possibility of regenerating lung
with stem cells.
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